These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11140927)

  • 1. A case of monosymptomatic hypochondriacal psychosis treated with olanzapine.
    Weintraub E; Robinson C
    Ann Clin Psychiatry; 2000 Dec; 12(4):247-9. PubMed ID: 11140927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis.
    Fawcett RG
    J Clin Psychiatry; 2002 Feb; 63(2):169. PubMed ID: 11874224
    [No Abstract]   [Full Text] [Related]  

  • 3. Monosymptomatic hypochondriacal psychosis: atypical presentation and response to olanzapine.
    Chand PK; Anand S; Murthy P
    J Clin Psychiatry; 2005 Jun; 66(6):800-1. PubMed ID: 15960578
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine treatment of monosymptomatic hypochondriacal psychosis.
    Nakaya M
    Gen Hosp Psychiatry; 2004; 26(2):166-7. PubMed ID: 15038937
    [No Abstract]   [Full Text] [Related]  

  • 5. Monosymptomatic hypochondriacal psychosis presenting with recurrent oral mucosal ulcers and multiple skin lesions responding to olanzapine treatment.
    Atilganoğlu U; Uğurad I; Arikan M; Ergün SS
    Int J Dermatol; 2006 Oct; 45(10):1189-92. PubMed ID: 17040437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A male case of monosymptomatic hypochondriacal psychosis responding to olanzapine: a case report.
    Ikenouchi A; Terao T; Nakamura J
    Pharmacopsychiatry; 2004 Sep; 37(5):240-1. PubMed ID: 15470804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of olanzapine for elderly patients with psychotic disorders: a review.
    Madhusoodanan S; Sinha S; Brenner R; Gupta S; Bogunovic O
    Ann Clin Psychiatry; 2001 Dec; 13(4):201-13. PubMed ID: 11958362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis.
    Elmer KB; George RM; Peterson K
    J Am Acad Dermatol; 2000 Oct; 43(4):683-6. PubMed ID: 11004627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine and negative symptoms.
    Rosen EH
    J Clin Psychiatry; 1998 Oct; 59(10):537-8. PubMed ID: 9818636
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Wolters EC; Jansen EN; Tuynman-Qua HG; Bergmans PL
    Neurology; 1996 Oct; 47(4):1085-7. PubMed ID: 8857751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of olanzapine for the treatment of geriatric psychosis.
    Hwang JP; Yang CH; Lee TW; Tsai SJ
    J Clin Psychopharmacol; 2003 Apr; 23(2):113-8. PubMed ID: 12640211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of high-dose olanzapine in refractory psychosis.
    Reich J
    Am J Psychiatry; 1999 Apr; 156(4):661. PubMed ID: 10200755
    [No Abstract]   [Full Text] [Related]  

  • 13. Polypharmacy of 2 atypical antipsychotics.
    Rhoads E
    J Clin Psychiatry; 2000 Sep; 61(9):678-80. PubMed ID: 11030491
    [No Abstract]   [Full Text] [Related]  

  • 14. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone for the treatment of monosymptomatic hypochondriacal psychosis.
    Cetin M; Ebrinç S; Ağargün MY; Yiğit S
    J Clin Psychiatry; 1999 Aug; 60(8):554. PubMed ID: 10485639
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia.
    Wolfgang SA
    Am J Health Syst Pharm; 1999 Nov; 56(21):2245-6. PubMed ID: 10565707
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
    Weiss EL; Longhurst JG; Bowers MB; Mazure CM
    J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.
    Street JS; Clark WS; Gannon KS; Cummings JL; Bymaster FP; Tamura RN; Mitan SJ; Kadam DL; Sanger TM; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2000 Oct; 57(10):968-76. PubMed ID: 11015815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomania-like syndrome induced by olanzapine.
    Simon AE; Aubry JM; Malky L; Bertschy G
    Int Clin Psychopharmacol; 1999 Nov; 14(6):377-8. PubMed ID: 10565806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.
    Schatz RA
    Ann Pharmacother; 2003 Sep; 37(9):1321-4. PubMed ID: 12921516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.